Insiders · STIM

Robert Cascella

Director at Neuronetics, Inc. (STIM) since April 2021

Robert Cascella has filed 59 insider reports with the SEC since April 2021, as director at Neuronetics, Inc. (STIM), director at Celestica Inc (CLS) and director at KORU Medical Systems, Inc. (KRMD) and at 1 more company. Robert Cascella made no open-market purchases or sales in the last 12 months. The latest filing, on November 16, 2026, reports grant or award at Neuronetics, Inc. (STIM).

Filings
59
Companies
4
Bought on market
$541K
Sold on market
None

Companies where Robert Cascella is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Neuronetics, Inc. logo
STIM
Neuronetics, Inc.
Directorsince April 2021798,017$492K$1.55$1.25-19%Nov 16, 2026
Celestica Inc logo
CLS
Celestica Inc
Directorsince December 2024272$201.80Oct 1, 2026
KORU Medical Systems, Inc. logo
KRMD
KORU Medical Systems, Inc.
Directorsince May 2022103,274$49.5K$2.61$3.19+22%Oct 1, 2026
Mirion Technologies, Inc. logo
MIR
Mirion Technologies, Inc.
Directorsince October 202160,801$16.07May 14, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Robert Cascella with

Other insiders at the same companies

Questions about Robert Cascella

What is Robert Cascella's role at Neuronetics, Inc.?
Robert Cascella reports to the SEC as director at Neuronetics, Inc. (STIM), according to the latest filing on November 16, 2026. Robert Cascella has also filed as director at Celestica Inc (CLS), director at KORU Medical Systems, Inc. (KRMD) and director at Mirion Technologies, Inc. (MIR).
How many shares does Robert Cascella own?
After the latest filing that states it, Robert Cascella directly owned 798,017 shares of Neuronetics, Inc. (STIM), 272 shares of Celestica Inc (CLS), 103,274 shares of KORU Medical Systems, Inc. (KRMD) and 60,801 shares of Mirion Technologies, Inc. (MIR). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Robert Cascella bought or sold stock recently?
The most recent open-market purchase was on September 12, 2024: bought 100,000 shares of Neuronetics, Inc. (STIM) for $75K at an average of $0.75.
How do I get alerts when Robert Cascella files?
Follow Robert Cascella on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert Cascella filed 3 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Robert Cascella (SEC CIK 0001218713). Totals count each trade once, skipping amendments whose original is on file, from Apr 5, 2021 on. View on SEC EDGAR · Get this as JSON